Actualités

Over the last six months, Alamo’s shares have sunk to $162.81, producing a disappointing 15.5% loss - a stark contrast to the S&P 500’s 8.7% gain. This might have investors contemplating their next move.

United Airlines' Q2 earnings beat estimates as strong yields and broad revenue gains offset soaring fuel costs and margin pressure.

J.B. Hunt's Q2 earnings beat estimates as intermodal growth, pricing and cost discipline lift revenues, operating income and margins.

Tower Semiconductor is making a bold $3 billion bet on Japan, expanding its manufacturing capacity and boosting investor confidence.

Gold miners just handed one of Wall Street's most punishing ETFs its best month in recent memory, and the reason has less to do with the metal itself than with a shift in the macro backdrop that caught a crowded trade completely off guard.

Advanced Micro Devices' market cap has more than doubled this year to around $840 billion.

Small-cap stocks are staging their most dominant run against the S&P 500 in over two decades, and three ETFs are competing for the best seat at the table. Which one actually comes out ahead may surprise you.

Abbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company reported second quarter 2026 results that topped Wall Street expectations and raised its full-year adjusted earnings guidance. The company posted adjusted diluted earnings per share of $1.31 for the...

UNH beats Q2 earnings estimates on lower medical costs and stronger Optum Insight, then raises its 2026 EPS and cash flow outlook.

ImmunityBio’s stock has surged 282.7% year to date, yet its overall valuation checks sit at a mixed 3 out of 6. This leaves investors weighing a powerful momentum story against signals that do not clearly flag the shares as cheap or expensive. The year to date gain of 282.7% suggests expectations around ImmunityBio have reset sharply higher. Fresh buyers are now paying a far richer price than they would have earlier in the year. Speculation around Anktiva’s potential role in bladder cancer...

Monolithic (MPWR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Microchip Tech (MCHP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Blackstone Inc. (BX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

General Motors (GM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The deal would combine two of the world’s largest delivery companies and roughly double Uber Eats’ global footprint.

I keep hitting the buy button on NVIDIA because of one policy decision, and I want to be blunt about it: the 25x quarterly dividend jump from $0.01 to $0.25 paired with a fresh $80 billion buyback authorization on top of the roughly $39 billion still remaining is the single clearest signal a management team ... This Single Nvidia Policy Keeps Me Hitting The Buy Button

Interactive Brokers (IBKR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Lumentum (LITE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Teledyne (TDY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MP Marerials' operating gains and strong liquidity support its rare earth buildout, but a premium valuation and unfinished project ramps favor patience.

DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.

SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.

Investing.com -- U.S.-listed shares of gold mining companies dropped in morning hours trading on Thursday, gold prices retreated, pressured by a surge in oil prices that reignited inflation concerns and clouded the outlook for U.S. interest rates.

CIEN and NOK are riding the AI networking boom, but which stock stands out as stronger based on growth, demand, valuation and outlook?

Reversing its 2025 trajectory, this hydrogen stock rocketed higher to start 2026.

Fred Alger Management, an investment management company, released its “Alger Capital Appreciation Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. US equities strongly rebounded in the second quarter, with the S&P 500 Index rising 15.2%. Easing geopolitical tensions and technological advancements fueled market optimism, propelling the Information Technology and […]

GE beats Q2 2026 estimates as commercial services, strong orders and cash flow fuel growth, prompting higher full-year guidance.

The stock is still 25% off all-time highs.

WMT's 36.74X forward P/E reflects confidence in digital growth but leaves little room for execution missteps.